{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T10:38:49Z","timestamp":1779878329529,"version":"3.53.1"},"publisher-location":"Singapore","reference-count":84,"publisher":"Springer Nature Singapore","isbn-type":[{"value":"9789819901128","type":"print"},{"value":"9789819901135","type":"electronic"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1007\/978-981-99-0113-5_15","type":"book-chapter","created":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T11:23:23Z","timestamp":1678879403000},"page":"279-297","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pseudotyped Viruses for Mammarenavirus"],"prefix":"10.1007","author":[{"given":"Qianqian","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youchun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,16]]},"reference":[{"key":"15_CR1","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1007\/s00705-021-05156-1","volume":"166","author":"PJ Walker","year":"2021","unstructured":"Walker, P.J., et al.: Changes to virus taxonomy and to the International Code of Virus Classification and Nomenclature ratified by the International Committee on Taxonomy of Viruses (2021). Arch. Virol. 166, 2633\u20132648 (2021). https:\/\/doi.org\/10.1007\/s00705-021-05156-1","journal-title":"Arch. Virol."},{"key":"15_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000455","volume":"5","author":"T Briese","year":"2009","unstructured":"Briese, T., et al.: Genetic detection and characterization of Lujo virus, a new hemorrhagic fever-associated arenavirus from southern Africa. PLoS Pathog. 5, e1000455 (2009). https:\/\/doi.org\/10.1371\/journal.ppat.1000455","journal-title":"PLoS Pathog."},{"key":"15_CR3","doi-asserted-by":"publisher","first-page":"802","DOI":"10.4269\/ajtmh.1965.14.802","volume":"14","author":"NH Wiebenga","year":"1965","unstructured":"Wiebenga, N.H.: Immunologic studies of Tacaribe, Junin and Machupo viruses. Am. J. Trop. Med. Hyg. 14, 802\u2013808 (1965). https:\/\/doi.org\/10.4269\/ajtmh.1965.14.802","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"15_CR4","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1007\/s00705-015-2418-y","volume":"160","author":"SR Radoshitzky","year":"2015","unstructured":"Radoshitzky, S.R., et al.: Past, present, and future of arenavirus taxonomy. Arch. Virol. 160, 1851\u20131874 (2015). https:\/\/doi.org\/10.1007\/s00705-015-2418-y","journal-title":"Arch. Virol."},{"key":"15_CR5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1056\/NEJM198601023140104","volume":"314","author":"JB McCormick","year":"1986","unstructured":"McCormick, J.B., et al.: Lassa fever. Effective therapy with ribavirin. N. Engl. J. Med. 314, 20\u201326 (1986). https:\/\/doi.org\/10.1056\/NEJM198601023140104","journal-title":"N. Engl. J. Med."},{"key":"15_CR6","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s00705-018-04127-3","volume":"164","author":"P Maes","year":"2019","unstructured":"Maes, P., et al.: Taxonomy of the order Bunyavirales: second update 2018. Arch. Virol. 164, 927\u2013941 (2019). https:\/\/doi.org\/10.1007\/s00705-018-04127-3","journal-title":"Arch. Virol."},{"key":"15_CR7","volume-title":"Fields Virology","author":"DM Knipe","year":"2013","unstructured":"Knipe, D.M., Howley, P.M.: Fields Virology, 6th edn. Lippincott Williams & Wilkins (2013)","edition":"6"},{"key":"15_CR8","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1126\/science.1252480","volume":"344","author":"LT Jae","year":"2014","unstructured":"Jae, L.T., et al.: Virus entry. Lassa virus entry requires a trigger-induced receptor switch. Science. 344, 1506\u20131510 (2014). https:\/\/doi.org\/10.1126\/science.1252480","journal-title":"Science"},{"key":"15_CR9","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/BF02122438","volume":"175","author":"JB McCormick","year":"1986","unstructured":"McCormick, J.B.: Clinical, epidemiologic, and therapeutic aspects of Lassa fever. Med. Microbiol. Immunol. 175, 153\u2013155 (1986)","journal-title":"Med. Microbiol. Immunol."},{"key":"15_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003398","volume":"9","author":"G Lo Iacono","year":"2015","unstructured":"Lo Iacono, G., et al.: Using modelling to disentangle the relative contributions of zoonotic and anthroponotic transmission: the case of Lassa fever. PLoS Negl. Trop. Dis. 9, e3398 (2015). https:\/\/doi.org\/10.1371\/journal.pntd.0003398","journal-title":"PLoS Negl. Trop. Dis."},{"key":"15_CR11","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/01.NURSE.0000482873.70955.7b","volume":"46","author":"AL Coyle","year":"2016","unstructured":"Coyle, A.L.: Lassa fever. Nursing. 46, 69\u201370 (2016). https:\/\/doi.org\/10.1097\/01.NURSE.0000482873.70955.7b","journal-title":"Nursing"},{"key":"15_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0009788","volume":"15","author":"L Merson","year":"2021","unstructured":"Merson, L., et al.: Clinical characterization of Lassa fever: A systematic review of clinical reports and research to inform clinical trial design. PLoS Negl. Trop. Dis. 15, e0009788 (2021). https:\/\/doi.org\/10.1371\/journal.pntd.0009788","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"Suppl 2","key":"15_CR13","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.1863-2378.2012.01469.x","volume":"59","author":"N Sogoba","year":"2012","unstructured":"Sogoba, N., Feldmann, H., Safronetz, D.: Lassa fever in West Africa: evidence for an expanded region of endemicity. Zoonoses Public Health. 59(Suppl 2), 43\u201347 (2012). https:\/\/doi.org\/10.1111\/j.1863-2378.2012.01469.x","journal-title":"Zoonoses Public Health"},{"key":"15_CR14","doi-asserted-by":"publisher","first-page":"160","DOI":"10.4149\/av_2013_02_160","volume":"57","author":"K Laposova","year":"2013","unstructured":"Laposova, K., Pastorekova, S., Tomaskova, J.: Lymphocytic choriomeningitis virus: invisible but not innocent. Acta Virol. 57, 160\u2013170 (2013)","journal-title":"Acta Virol."},{"issue":"Suppl 1","key":"15_CR15","doi-asserted-by":"publisher","first-page":"E57","DOI":"10.1111\/j.1749-6632.2009.05048.x","volume":"1171","author":"JC de la Torre","year":"2009","unstructured":"de la Torre, J.C.: Molecular and cell biology of the prototypic arenavirus LCMV: implications for understanding and combating hemorrhagic fever arenaviruses. Ann. N. Y. Acad. Sci. 1171(Suppl 1), E57\u2013E64 (2009). https:\/\/doi.org\/10.1111\/j.1749-6632.2009.05048.x","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"15_CR16","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1056\/NEJMoa053240","volume":"354","author":"SA Fischer","year":"2006","unstructured":"Fischer, S.A., et al.: Transmission of lymphocytic choriomeningitis virus by organ transplantation. N. Engl. J. Med. 354, 2235\u20132249 (2006). https:\/\/doi.org\/10.1056\/NEJMoa053240","journal-title":"N. Engl. J. Med."},{"key":"15_CR17","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.cell.2015.07.020","volume":"162","author":"KG Andersen","year":"2015","unstructured":"Andersen, K.G., et al.: Clinical Sequencing Uncovers Origins and Evolution of Lassa Virus. Cell. 162, 738\u2013750 (2015). https:\/\/doi.org\/10.1016\/j.cell.2015.07.020","journal-title":"Cell"},{"key":"15_CR18","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.coviro.2019.07.009","volume":"37","author":"LE Garnett","year":"2019","unstructured":"Garnett, L.E., Strong, J.E.: Lassa fever: With 50 years of study, hundreds of thousands of patients and an extremely high disease burden, what have we learned? Curr. Opin. Virol. 37, 123\u2013131 (2019). https:\/\/doi.org\/10.1016\/j.coviro.2019.07.009","journal-title":"Curr. Opin. Virol."},{"key":"15_CR19","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3201\/eid2403.171905","volume":"24","author":"SLM Whitmer","year":"2018","unstructured":"Whitmer, S.L.M., et al.: New Lineage of Lassa Virus, Togo, 2016. Emerg. Infect. Dis. 24, 599\u2013602 (2018). https:\/\/doi.org\/10.3201\/eid2403.171905","journal-title":"Emerg. Infect. Dis."},{"key":"15_CR20","doi-asserted-by":"publisher","unstructured":"Lukashevich, I.S., Paessler, S., de la Torre, J.C.: Lassa virus diversity and feasibility for universal prophylactic vaccine. F1000Res. 8 (2019). https:\/\/doi.org\/10.12688\/f1000research.16989.1","DOI":"10.12688\/f1000research.16989.1"},{"key":"15_CR21","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1128\/JCM.00170-17","volume":"55","author":"V Raabe","year":"2017","unstructured":"Raabe, V., Koehler, J.: Laboratory Diagnosis of Lassa Fever. J. Clin. Microbiol. 55, 1629\u20131637 (2017). https:\/\/doi.org\/10.1128\/JCM.00170-17","journal-title":"J. Clin. Microbiol."},{"key":"15_CR22","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.3201\/eid2710.210224","volume":"27","author":"A Fornuskova","year":"2021","unstructured":"Fornuskova, A., Hiadlovska, Z., Macholan, M., Pialek, J., de Bellocq, J.G.: New Perspective on the Geographic Distribution and Evolution of Lymphocytic Choriomeningitis Virus, Central Europe. Emerg. Infect. Dis. 27, 2638\u20132647 (2021). https:\/\/doi.org\/10.3201\/eid2710.210224","journal-title":"Emerg. Infect. Dis."},{"key":"15_CR23","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.3201\/eid1607.091902","volume":"16","author":"CG Albarino","year":"2010","unstructured":"Albarino, C.G., et al.: High diversity and ancient common ancestry of lymphocytic choriomeningitis virus. Emerg. Infect. Dis. 16, 1093\u20131100 (2010). https:\/\/doi.org\/10.3201\/eid1607.091902","journal-title":"Emerg. Infect. Dis."},{"key":"15_CR24","doi-asserted-by":"publisher","unstructured":"Martinez-Sobrido, L., de la Torre, J.C.: Reporter-Expressing, Replicating-Competent Recombinant Arenaviruses. Viruses. 8 (2016). https:\/\/doi.org\/10.3390\/v8070197","DOI":"10.3390\/v8070197"},{"key":"15_CR25","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1128\/JVI.02229-10","volume":"85","author":"WW Rodrigo","year":"2011","unstructured":"Rodrigo, W.W., de la Torre, J.C., Martinez-Sobrido, L.: Use of single-cycle infectious lymphocytic choriomeningitis virus to study hemorrhagic fever arenaviruses. J. Virol. 85, 1684\u20131695 (2011). https:\/\/doi.org\/10.1128\/JVI.02229-10","journal-title":"J. Virol."},{"key":"15_CR26","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1099\/vir.0.2008\/000349-0","volume":"89","author":"E Wright","year":"2008","unstructured":"Wright, E., et al.: Investigating antibody neutralization of lyssaviruses using lentiviral pseudotypes: a cross-species comparison. J. Gen. Virol. 89, 2204\u20132213 (2008). https:\/\/doi.org\/10.1099\/vir.0.2008\/000349-0","journal-title":"J. Gen. Virol."},{"key":"15_CR27","doi-asserted-by":"publisher","first-page":"5172","DOI":"10.1016\/j.vaccine.2017.07.101","volume":"35","author":"Q Li","year":"2017","unstructured":"Li, Q., et al.: An LASV GPC pseudotyped virus based reporter system enables evaluation of vaccines in mice under non-BSL-4 conditions. Vaccine. 35, 5172\u20135178 (2017). https:\/\/doi.org\/10.1016\/j.vaccine.2017.07.101","journal-title":"Vaccine"},{"key":"15_CR28","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1038\/sj.gt.3301292","volume":"7","author":"D Negre","year":"2000","unstructured":"Negre, D., et al.: Characterization of novel safe lentiviral vectors derived from simian immunodeficiency virus (SIVmac251) that efficiently transduce mature human dendritic cells. Gene Ther. 7, 1613\u20131623 (2000). https:\/\/doi.org\/10.1038\/sj.gt.3301292","journal-title":"Gene Ther."},{"key":"15_CR29","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/s0300-9084(02)00036-6","volume":"84","author":"D Negre","year":"2002","unstructured":"Negre, D., Cosset, F.L.: Vectors derived from simian immunodeficiency virus (SIV). Biochimie. 84, 1161\u20131171 (2002). https:\/\/doi.org\/10.1016\/s0300-9084(02)00036-6","journal-title":"Biochimie"},{"key":"15_CR30","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1006\/mthe.2002.0690","volume":"6","author":"G Duisit","year":"2002","unstructured":"Duisit, G., et al.: Five recombinant simian immunodeficiency virus pseudotypes lead to exclusive transduction of retinal pigmented epithelium in rat. Mol. Ther. 6, 446\u2013454 (2002). https:\/\/doi.org\/10.1006\/mthe.2002.0690","journal-title":"Mol. Ther."},{"key":"15_CR31","doi-asserted-by":"publisher","first-page":"4991","DOI":"10.1128\/JVI.73.6.4991-5000.1999","volume":"73","author":"JC Johnston","year":"1999","unstructured":"Johnston, J.C., et al.: Minimum requirements for efficient transduction of dividing and nondividing cells by feline immunodeficiency virus vectors. J. Virol. 73, 4991\u20135000 (1999). https:\/\/doi.org\/10.1128\/JVI.73.6.4991-5000.1999","journal-title":"J. Virol."},{"key":"15_CR32","doi-asserted-by":"publisher","first-page":"R55","DOI":"10.1172\/JCI8390","volume":"104","author":"G Wang","year":"1999","unstructured":"Wang, G., et al.: Feline immunodeficiency virus vectors persistently transduce nondividing airway epithelia and correct the cystic fibrosis defect. J. Clin. Invest. 104, R55\u2013R62 (1999). https:\/\/doi.org\/10.1172\/JCI8390","journal-title":"J. Clin. Invest."},{"key":"15_CR33","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1479-0556-9-8","volume":"9","author":"DE Dylla","year":"2011","unstructured":"Dylla, D.E., Xie, L., Michele, D.E., Kunz, S., McCray Jr., P.B.: Altering alpha-dystroglycan receptor affinity of LCMV pseudotyped lentivirus yields unique cell and tissue tropism. Genet. Vaccines. Ther. 9, 8 (2011). https:\/\/doi.org\/10.1186\/1479-0556-9-8","journal-title":"Genet. Vaccines. Ther."},{"key":"15_CR34","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.ymthe.2004.11.008","volume":"11","author":"CS Stein","year":"2005","unstructured":"Stein, C.S., Martins, I., Davidson, B.L.: The lymphocytic choriomeningitis virus envelope glycoprotein targets lentiviral gene transfer vector to neural progenitors in the murine brain. Mol. Ther. 11, 382\u2013389 (2005). https:\/\/doi.org\/10.1016\/j.ymthe.2004.11.008","journal-title":"Mol. Ther."},{"key":"15_CR35","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1080\/22221751.2020.1743767","volume":"9","author":"J Nie","year":"2020","unstructured":"Nie, J., et al.: Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2. Emerg. Microbes. Infect. 9, 680\u2013686 (2020). https:\/\/doi.org\/10.1080\/22221751.2020.1743767","journal-title":"Emerg. Microbes. Infect"},{"key":"15_CR36","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.3390\/v4102097","volume":"4","author":"S Fukushi","year":"2012","unstructured":"Fukushi, S., Tani, H., Yoshikawa, T., Saijo, M., Morikawa, S.: Serological assays based on recombinant viral proteins for the diagnosis of arenavirus hemorrhagic fevers. Viruses. 4, 2097\u20132114 (2012). https:\/\/doi.org\/10.3390\/v4102097","journal-title":"Viruses"},{"key":"15_CR37","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1093\/nar\/23.4.628","volume":"23","author":"Y Soneoka","year":"1995","unstructured":"Soneoka, Y., et al.: A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res. 23, 628\u2013633 (1995)","journal-title":"Nucleic Acids Res."},{"key":"15_CR38","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1128\/jvi.76.3.1488-1495.2002","volume":"76","author":"WR Beyer","year":"2002","unstructured":"Beyer, W.R., Westphal, M., Ostertag, W., von Laer, D.: Oncoretrovirus and lentivirus vectors pseudotyped with lymphocytic choriomeningitis virus glycoprotein: generation, concentration, and broad host range. J. Virol. 76, 1488\u20131495 (2002). https:\/\/doi.org\/10.1128\/jvi.76.3.1488-1495.2002","journal-title":"J. Virol."},{"key":"15_CR39","doi-asserted-by":"publisher","first-page":"6114","DOI":"10.1128\/JVI.73.7.6114-6116.1999","volume":"73","author":"H Miletic","year":"1999","unstructured":"Miletic, H., et al.: Retroviral vectors pseudotyped with lymphocytic choriomeningitis virus. J. Virol. 73, 6114\u20136116 (1999). https:\/\/doi.org\/10.1128\/JVI.73.7.6114-6116.1999","journal-title":"J. Virol."},{"key":"15_CR40","doi-asserted-by":"publisher","unstructured":"Lay Mendoza, M.F., Acciani, M.D., Levit, C.N., Santa Maria, C., Brindley, M.A.: Monitoring Viral Entry in Real-Time Using a Luciferase Recombinant Vesicular Stomatitis Virus Producing SARS-CoV-2, EBOV, LASV, CHIKV, and VSV Glycoproteins. Viruses. 12 (2020). https:\/\/doi.org\/10.3390\/v12121457","DOI":"10.3390\/v12121457"},{"key":"15_CR41","doi-asserted-by":"publisher","unstructured":"Cai, Y., et al.: Recombinant Lassa Virus Expressing Green Fluorescent Protein as a Tool for High-Throughput Drug Screens and Neutralizing Antibody Assays. Viruses. 10 (2018). https:\/\/doi.org\/10.3390\/v10110655","DOI":"10.3390\/v10110655"},{"key":"15_CR42","doi-asserted-by":"publisher","unstructured":"Fedeli, C., et al.: Axl Can Serve as Entry Factor for Lassa Virus Depending on the Functional Glycosylation of Dystroglycan. J. Virol. 92 (2018). https:\/\/doi.org\/10.1128\/JVI.01613-17","DOI":"10.1128\/JVI.01613-17"},{"key":"15_CR43","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01165-21","volume":"95","author":"MD Acciani","year":"2021","unstructured":"Acciani, M.D., et al.: Ebola Virus Requires Phosphatidylserine Scrambling Activity for Efficient Budding and Optimal Infectivity. J. Virol. 95, e0116521 (2021). https:\/\/doi.org\/10.1128\/JVI.01165-21","journal-title":"J. Virol."},{"key":"15_CR44","doi-asserted-by":"publisher","first-page":"18734","DOI":"10.1074\/jbc.M802089200","volume":"283","author":"AM Lee","year":"2008","unstructured":"Lee, A.M., et al.: Unique small molecule entry inhibitors of hemorrhagic fever arenaviruses. J. Biol. Chem. 283, 18734\u201318742 (2008). https:\/\/doi.org\/10.1074\/jbc.M802089200","journal-title":"J. Biol. Chem."},{"key":"15_CR45","doi-asserted-by":"publisher","unstructured":"Torriani, G., et al.: Identification of Clotrimazole Derivatives as Specific Inhibitors of Arenavirus Fusion. J. Virol. 93 (2019). https:\/\/doi.org\/10.1128\/JVI.01744-18","DOI":"10.1128\/JVI.01744-18"},{"key":"15_CR46","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.apsb.2020.02.014","volume":"10","author":"K Tang","year":"2020","unstructured":"Tang, K., Zhang, X., Guo, Y.: Identification of the dietary supplement capsaicin as an inhibitor of Lassa virus entry. Acta Pharm. Sin. B. 10, 789\u2013798 (2020). https:\/\/doi.org\/10.1016\/j.apsb.2020.02.014","journal-title":"Acta Pharm. Sin. B"},{"key":"15_CR47","doi-asserted-by":"publisher","unstructured":"Herring, S., et al.: Inhibition of Arenaviruses by Combinations of Orally Available Approved Drugs. Antimicrob. Agents Chemother. 65 (2021). https:\/\/doi.org\/10.1128\/AAC.01146-20","DOI":"10.1128\/AAC.01146-20"},{"key":"15_CR48","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s11060-004-6046-8","volume":"70","author":"S Steffens","year":"2004","unstructured":"Steffens, S., et al.: Transduction of human glial and neuronal tumor cells with different lentivirus vector pseudotypes. J. Neuro-Oncol. 70, 281\u2013288 (2004). https:\/\/doi.org\/10.1007\/s11060-004-6046-8","journal-title":"J. Neuro-Oncol."},{"key":"15_CR49","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1089\/hgtb.2014.105","volume":"25","author":"C Zhang","year":"2014","unstructured":"Zhang, C., Hu, B., Xiao, L., Liu, Y., Wang, P.: Pseudotyping lentiviral vectors with lymphocytic choriomeningitis virus glycoproteins for transduction of dendritic cells and in vivo immunization. Hum. Gene. Ther. Methods. 25, 328\u2013338 (2014). https:\/\/doi.org\/10.1089\/hgtb.2014.105","journal-title":"Hum. Gene. Ther. Methods."},{"key":"15_CR50","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1292\/jvms.12-0176","volume":"74","author":"M Shimojima","year":"2012","unstructured":"Shimojima, M., Kawaoka, Y.: Cell surface molecules involved in infection mediated by lymphocytic choriomeningitis virus glycoprotein. J. Vet. Med. Sci. 74, 1363\u20131366 (2012). https:\/\/doi.org\/10.1292\/jvms.12-0176","journal-title":"J. Vet. Med. Sci."},{"key":"15_CR51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009996","volume":"17","author":"A Volland","year":"2021","unstructured":"Volland, A., et al.: Heparan sulfate proteoglycans serve as alternative receptors for low affinity LCMV variants. PLoS Pathog. 17, e1009996 (2021). https:\/\/doi.org\/10.1371\/journal.ppat.1009996","journal-title":"PLoS Pathog."},{"key":"15_CR52","doi-asserted-by":"publisher","first-page":"5979","DOI":"10.1128\/JVI.79.10.5979-5987.2005","volume":"79","author":"S Kunz","year":"2005","unstructured":"Kunz, S., Rojek, J.M., Perez, M., Spiropoulou, C.F., Oldstone, M.B.: Characterization of the interaction of Lassa fever virus with its cellular receptor alpha-dystroglycan. J. Virol. 79, 5979\u20135987 (2005). https:\/\/doi.org\/10.1128\/JVI.79.10.5979-5987.2005","journal-title":"J. Virol."},{"key":"15_CR53","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.virol.2006.05.018","volume":"353","author":"T Reignier","year":"2006","unstructured":"Reignier, T., et al.: Receptor use by pathogenic arenaviruses. Virology. 353, 111\u2013120 (2006). https:\/\/doi.org\/10.1016\/j.virol.2006.05.018","journal-title":"Virology"},{"key":"15_CR54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003232","volume":"9","author":"S Jemielity","year":"2013","unstructured":"Jemielity, S., et al.: TIM-family proteins promote infection of multiple enveloped viruses through virion-associated phosphatidylserine. PLoS Pathog. 9, e1003232 (2013). https:\/\/doi.org\/10.1371\/journal.ppat.1003232","journal-title":"PLoS Pathog."},{"key":"15_CR55","doi-asserted-by":"publisher","unstructured":"Brouillette, R.B., et al.: TIM-1 Mediates Dystroglycan-Independent Entry of Lassa Virus. J. Virol. 92 (2018). https:\/\/doi.org\/10.1128\/JVI.00093-18","DOI":"10.1128\/JVI.00093-18"},{"key":"15_CR56","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nature05539","volume":"446","author":"SR Radoshitzky","year":"2007","unstructured":"Radoshitzky, S.R., et al.: Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses. Nature. 446, 92\u201396 (2007). https:\/\/doi.org\/10.1038\/nature05539","journal-title":"Nature"},{"key":"15_CR57","doi-asserted-by":"publisher","first-page":"7317","DOI":"10.1128\/JVI.00512-14","volume":"88","author":"H Tani","year":"2014","unstructured":"Tani, H., et al.: Analysis of Lujo virus cell entry using pseudotype vesicular stomatitis virus. J. Virol. 88, 7317\u20137330 (2014). https:\/\/doi.org\/10.1128\/JVI.00512-14","journal-title":"J. Virol."},{"key":"15_CR58","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1128\/jvi.77.5.2866-2872.2003","volume":"77","author":"WR Beyer","year":"2003","unstructured":"Beyer, W.R., Popplau, D., Garten, W., von Laer, D., Lenz, O.: Endoproteolytic processing of the lymphocytic choriomeningitis virus glycoprotein by the subtilase SKI-1\/S1P. J. Virol. 77, 2866\u20132872 (2003). https:\/\/doi.org\/10.1128\/jvi.77.5.2866-2872.2003","journal-title":"J. Virol."},{"key":"15_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.virol.2007.07.014","volume":"369","author":"EM Vela","year":"2007","unstructured":"Vela, E.M., Zhang, L., Colpitts, T.M., Davey, R.A., Aronson, J.F.: Arenavirus entry occurs through a cholesterol-dependent, non-caveolar, clathrin-mediated endocytic mechanism. Virology. 369, 1\u201311 (2007). https:\/\/doi.org\/10.1016\/j.virol.2007.07.014","journal-title":"Virology"},{"key":"15_CR60","doi-asserted-by":"publisher","unstructured":"Hulseberg, C.E., Feneant, L., Szymanska, K.M., White, J.M.: Lamp1 Increases the Efficiency of Lassa Virus Infection by Promoting Fusion in Less Acidic Endosomal Compartments. MBio. 9 (2018). https:\/\/doi.org\/10.1128\/mBio.01818-17","DOI":"10.1128\/mBio.01818-17"},{"key":"15_CR61","doi-asserted-by":"publisher","unstructured":"Bulow, U., Govindan, R., Munro, J.B.: Acidic pH Triggers Lipid Mixing Mediated by Lassa Virus GP. Viruses. 12 (2020). https:\/\/doi.org\/10.3390\/v12070716","DOI":"10.3390\/v12070716"},{"key":"15_CR62","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009488","volume":"17","author":"RM Markosyan","year":"2021","unstructured":"Markosyan, R.M., Marin, M., Zhang, Y., Cohen, F.S., Melikyan, G.B.: The late endosome-resident lipid bis(monoacylglycero)phosphate is a cofactor for Lassa virus fusion. PLoS Pathog. 17, e1009488 (2021). https:\/\/doi.org\/10.1371\/journal.ppat.1009488","journal-title":"PLoS Pathog."},{"key":"15_CR63","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/jmv.1890120203","volume":"12","author":"PB Jahrling","year":"1983","unstructured":"Jahrling, P.B.: Protection of Lassa virus-infected guinea pigs with Lassa-immune plasma of guinea pig, primate, and human origin. J. Med. Virol. 12, 93\u2013102 (1983). https:\/\/doi.org\/10.1002\/jmv.1890120203","journal-title":"J. Med. Virol."},{"key":"15_CR64","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3390\/vaccines1030262","volume":"1","author":"KA Cashman","year":"2013","unstructured":"Cashman, K.A., et al.: Enhanced Efficacy of a Codon-Optimized DNA Vaccine Encoding the Glycoprotein Precursor Gene of Lassa Virus in a Guinea Pig Disease Model When Delivered by Dermal Electroporation. Vaccine. 1, 262\u2013277 (2013). https:\/\/doi.org\/10.3390\/vaccines1030262","journal-title":"Vaccine"},{"key":"15_CR65","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1128\/JVI.03035-13","volume":"88","author":"JC Zapata","year":"2014","unstructured":"Zapata, J.C., et al.: Genetic variation in vitro and in vivo of an attenuated Lassa vaccine candidate. J. Virol. 88, 3058\u20133066 (2014). https:\/\/doi.org\/10.1128\/JVI.03035-13","journal-title":"J. Virol."},{"key":"15_CR66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0020183","volume":"2","author":"TW Geisbert","year":"2005","unstructured":"Geisbert, T.W., et al.: Development of a new vaccine for the prevention of Lassa fever. PLoS Med. 2, e183 (2005). https:\/\/doi.org\/10.1371\/journal.pmed.0020183","journal-title":"PLoS Med."},{"key":"15_CR67","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1080\/14760584.2016.1184575","volume":"15","author":"IS Lukashevich","year":"2016","unstructured":"Lukashevich, I.S., Pushko, P.: Vaccine platforms to control Lassa fever. Expert Rev. Vaccines. 15, 1135\u20131150 (2016). https:\/\/doi.org\/10.1080\/14760584.2016.1184575","journal-title":"Expert Rev. Vaccines"},{"key":"15_CR68","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1080\/21645515.2019.1616499","volume":"15","author":"J Jiang","year":"2019","unstructured":"Jiang, J., et al.: Immunogenicity of a protective intradermal DNA vaccine against Lassa virus in cynomolgus macaques. Hum. Vaccin. Immunother. 15, 2066\u20132074 (2019). https:\/\/doi.org\/10.1080\/21645515.2019.1616499","journal-title":"Hum. Vaccin. Immunother."},{"key":"15_CR69","doi-asserted-by":"publisher","unstructured":"Wang, M., et al.: Construction and Immunological Evaluation of an Adenoviral Vector-Based Vaccine Candidate for Lassa Fever. Viruses. 13 (2021). https:\/\/doi.org\/10.3390\/v13030484","DOI":"10.3390\/v13030484"},{"key":"15_CR70","doi-asserted-by":"publisher","unstructured":"Jiang, J. et al. Multivalent DNA Vaccines as A Strategy to Combat Multiple Concurrent Epidemics: Mosquito-Borne and Hemorrhagic Fever Viruses. Viruses 13, https:\/\/doi.org\/10.3390\/v13030382 (2021)","DOI":"10.3390\/v13030382"},{"key":"15_CR71","doi-asserted-by":"publisher","first-page":"16030","DOI":"10.1038\/s41598-020-72539-w","volume":"10","author":"ML Heinrich","year":"2020","unstructured":"Heinrich, M.L., et al.: Antibodies from Sierra Leonean and Nigerian Lassa fever survivors cross-react with recombinant proteins representing Lassa viruses of divergent lineages. Sci. Rep. 10, 16030 (2020). https:\/\/doi.org\/10.1038\/s41598-020-72539-w","journal-title":"Sci. Rep."},{"key":"15_CR72","doi-asserted-by":"publisher","unstructured":"Basu, A., Mills, D. M. & Bowlin, T. L. High-throughput screening of viral entry inhibitors using pseudotyped virus. Curr. Protoc. Pharmacol. Chapter 13, Unit 13B 13, https:\/\/doi.org\/10.1002\/0471141755.ph13b03s51 (2010)","DOI":"10.1002\/0471141755.ph13b03s51"},{"key":"15_CR73","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.virol.2010.11.022","volume":"411","author":"AM Lee","year":"2011","unstructured":"Lee, A.M., Pasquato, A., Kunz, S.: Novel approaches in anti-arenaviral drug development. Virology. 411, 163\u2013169 (2011). https:\/\/doi.org\/10.1016\/j.virol.2010.11.022","journal-title":"Virology"},{"key":"15_CR74","doi-asserted-by":"publisher","first-page":"10768","DOI":"10.1128\/JVI.00941-08","volume":"82","author":"RA Larson","year":"2008","unstructured":"Larson, R.A., et al.: Identification of a broad-spectrum arenavirus entry inhibitor. J. Virol. 82, 10768\u201310775 (2008). https:\/\/doi.org\/10.1128\/JVI.00941-08","journal-title":"J. Virol."},{"key":"15_CR75","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007439","volume":"14","author":"IG Madu","year":"2018","unstructured":"Madu, I.G., et al.: A potent Lassa virus antiviral targets an arenavirus virulence determinant. PLoS Pathog. 14, e1007439 (2018). https:\/\/doi.org\/10.1371\/journal.ppat.1007439","journal-title":"PLoS Pathog."},{"key":"15_CR76","doi-asserted-by":"publisher","unstructured":"Wang, P., et al.: Screening and Identification of Lassa Virus Entry Inhibitors from an FDA-Approved Drug Library. J. Virol. 92 (2018). https:\/\/doi.org\/10.1128\/JVI.00954-18","DOI":"10.1128\/JVI.00954-18"},{"key":"15_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2019.104701","volume":"174","author":"X Zhang","year":"2020","unstructured":"Zhang, X., Tang, K., Guo, Y.: The antifungal isavuconazole inhibits the entry of Lassa virus by targeting the stable signal peptide-GP2 subunit interface of Lassa virus glycoprotein. Antivir. Res. 174, 104701 (2020). https:\/\/doi.org\/10.1016\/j.antiviral.2019.104701","journal-title":"Antivir. Res."},{"key":"15_CR78","doi-asserted-by":"publisher","unstructured":"Takenaga, T., et al.: CP100356 Hydrochloride, a P-Glycoprotein Inhibitor, Inhibits Lassa Virus Entry: Implication of a Candidate Pan-Mammarenavirus Entry Inhibitor. Viruses. 13 (2021). https:\/\/doi.org\/10.3390\/v13091763","DOI":"10.3390\/v13091763"},{"key":"15_CR79","doi-asserted-by":"publisher","first-page":"e02063","DOI":"10.1128\/mBio.02063-14","volume":"5","author":"LH Bederka","year":"2014","unstructured":"Bederka, L.H., Bonhomme, C.J., Ling, E.L., Buchmeier, M.J.: Arenavirus stable signal peptide is the keystone subunit for glycoprotein complex organization. MBio. 5, e02063 (2014). https:\/\/doi.org\/10.1128\/mBio.02063-14","journal-title":"MBio"},{"key":"15_CR80","doi-asserted-by":"publisher","first-page":"6799","DOI":"10.1128\/JVI.00597-16","volume":"90","author":"S Shankar","year":"2016","unstructured":"Shankar, S., et al.: Small-Molecule Fusion Inhibitors Bind the pH-Sensing Stable Signal Peptide-GP2 Subunit Interface of the Lassa Virus Envelope Glycoprotein. J. Virol. 90, 6799\u20136807 (2016). https:\/\/doi.org\/10.1128\/JVI.00597-16","journal-title":"J. Virol."},{"key":"15_CR81","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1177\/1087057113494405","volume":"19","author":"J Wang","year":"2014","unstructured":"Wang, J., et al.: A comparative high-throughput screening protocol to identify entry inhibitors of enveloped viruses. J. Biomol. Screen. 19, 100\u2013107 (2014). https:\/\/doi.org\/10.1177\/1087057113494405","journal-title":"J. Biomol. Screen."},{"key":"15_CR82","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1002\/jmv.24705","volume":"89","author":"Y Yang","year":"2017","unstructured":"Yang, Y., et al.: A cell-based high-throughput protocol to screen entry inhibitors of highly pathogenic viruses with Traditional Chinese Medicines. J. Med. Virol. 89, 908\u2013916 (2017). https:\/\/doi.org\/10.1002\/jmv.24705","journal-title":"J. Med. Virol."},{"key":"15_CR83","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.virol.2012.07.009","volume":"433","author":"N Kumar","year":"2012","unstructured":"Kumar, N., et al.: Characterization of virulence-associated determinants in the envelope glycoprotein of Pichinde virus. Virology. 433, 97\u2013103 (2012). https:\/\/doi.org\/10.1016\/j.virol.2012.07.009","journal-title":"Virology"},{"key":"15_CR84","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1007\/s12250-021-00358-y","volume":"36","author":"X Zhu","year":"2021","unstructured":"Zhu, X., et al.: Effects of N-Linked Glycan on Lassa Virus Envelope Glycoprotein Cleavage, Infectivity, and Immune Response. Virol. Sin. 36, 774\u2013783 (2021). https:\/\/doi.org\/10.1007\/s12250-021-00358-y","journal-title":"Virol. Sin."}],"container-title":["Advances in Experimental Medicine and Biology","Pseudotyped Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-99-0113-5_15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T11:25:35Z","timestamp":1678879535000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-981-99-0113-5_15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9789819901128","9789819901135"],"references-count":84,"URL":"https:\/\/doi.org\/10.1007\/978-981-99-0113-5_15","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"16 March 2023","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}